Dysphagia after stroke is a common symptom reported in 28%-65% of patients [1]. As various parts of the brain are involved in swallowing, clinical manifestations of swallowing disorder vary [2]. Cricopharyngeal dysphagia (CPD) is a swallowing disorder caused by an inappropriate constriction of the cri-copharyngeal muscle, and the medulla is the most causative location [3]. To date, CPD treatment is focused on the relaxation of the cricopharyngeus muscle, for which methods such as injection of botulinum neurotoxin (BoNT), balloon dilatation, and myotomy are often used [4]. Meanwhile, little is known about pharmacotherapy. Apart from CPD, inappropriate relaxation of the pha-Annals of Rehabilitation Medicine